INLUPREVE Trademark

Trademark Overview

On Wednesday, December 11, 2024, a trademark application was filed for INLUPREVE with the United States Patent and Trademark Office. The USPTO has given the INLUPREVE trademark a serial number of 98896134. The federal status of this trademark filing is ABANDONED - EXPRESS as of Saturday, April 12, 2025. This trademark is owned by GlaxoSmithKline Biologicals SA. The INLUPREVE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases
inlupreve

General Information

Serial Number98896134
Word MarkINLUPREVE
Filing DateWednesday, December 11, 2024
Status601 - ABANDONED - EXPRESS
Status DateSaturday, April 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 11, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events

Event DateEvent Description
Wednesday, December 11, 2024NEW APPLICATION ENTERED
Wednesday, December 11, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 12, 2025ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Friday, April 11, 2025TEAS EXPRESS ABANDONMENT RECEIVED
Saturday, April 12, 2025ABANDONMENT - EXPRESS MAILED

Related Keywords

inlupreve diseases preparations pharmaceutical infectious treatment system psychiatric immune dermatological neurological